Novartis India Limited is an India-based company. The Company is primarily engaged in the business of trading of Pharmaceuticals. It operates in the Pharmaceutical business segment. The Company’s brands hold key positions in therapeutic areas, such as, Voveran, which is the brand for bone and pain; Simulect, Certican, Sandimmun, Neoral, and Myfortic, which is the brand for transplantation immunology; and Tegrital and Exelon, which is the brand for neurosciences.As of 26 May 2026, Novartis India share price is ₹1,360.20. The stock opened at ₹1,335.00, compared to its previous close of ₹1,365.30. During today's trading session, Novartis India share price moved in the range of ₹1,322.00 to ₹1,425.00, with an average price of ₹1,373.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,322.00 and a high of ₹1,425.00. On the performance front, Novartis India share price has increased by 36.64% over the last six months and is up 36.64% on a year-on-year basis.
The market capitalization of Novartis India is ₹3,364 Crs, with a P/E ratio of 36.1 and a dividend yield of 0.00%.